BMJ  2008;336:1246-1248 (31 May), doi:10.1136/bmj.39554.624086.AD

Practice

Guidelines

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

¹ National Collaborating Centre for Primary Care, Royal College of General Practitioners, London SW7 1PU

The first 150 words of the full text of this article appear below.

Why read this summary?

Cardiovascular disease remains a leading cause of morbidity and mortality in the United Kingdom. Randomised controlled trials have shown benefit from modifying risk factors in people at risk of developing cardiovascular disease and in those who have evidence of established disease. Currently patients are often assessed opportunistically and treated on the basis of individual clinical or laboratory results rather than on their overall level of risk of developing cardiovascular disease. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the effective identification and assessment of people at risk of cardiovascular disease, and on the modification of lipids in primary and secondary prevention. The detailed consideration of the evidence is available in the full guideline (www.nice.org.uk/ CG67).¹

Recommendations

NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development group’s . . . [Full text of this article]

Identifying those at risk of cardiovascular disease for primary prevention
Communicating cardiovascular risk with the patient
Lifestyle advice
Drug treatment for lipid modification in primary and secondary prevention
Statins for primary prevention
Statins for secondary prevention
Monitoring statin treatment
Other lipid lowering agents

Overcoming barriers

Further information on the guidance
Methods
Future research

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease

Francesco P Cappuccio
BMJ 2008 336: 1248-1249. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

NICE Lipid modification guidance

Stuart J Laurie
bmj.com, 31 May 2008 [Full text]

Sibling cardiovascular disease (CVD) is a stronger risk factor than parental CVD for premature CVD

Mark N Upton
bmj.com, 1 Jun 2008 [Full text]